<?xml version="1.0" encoding="UTF-8"?>
<rss xmlns:dc="http://purl.org/dc/elements/1.1/" version="2.0">
  <channel>
    <title>DSpace Collection:</title>
    <link>https://repositorio.ufu.br/handle/123456789/5487</link>
    <description />
    <pubDate>Thu, 06 Aug 2026 14:54:01 GMT</pubDate>
    <dc:date>2026-08-06T14:54:01Z</dc:date>
    <item>
      <title>Caracterização molecular de Escherichia coli multirresistente na interface humano- animal-ambiental: uma abordagem One Health</title>
      <link>https://repositorio.ufu.br/handle/123456789/49312</link>
      <description>Title: Caracterização molecular de Escherichia coli multirresistente na interface humano- animal-ambiental: uma abordagem One Health
Abstract: In the context of the One Health approach, microorganisms such as Escherichia coli have received increasing attention due to their widespread presence at the human-animal-environment interface and their ability to disseminate antimicrobial resistance genes, highlighting their role as resistance vectors. The aim of this study was to investigate the clonal dissemination of resistant E. coli isolated from the human-animal-environment interface, characterizing their resistance and virulence genes, as well as sequence types (STs), in order to evaluate their role in the circulation of these strains from the perspective of the One Health approach. This study adopted two complementary approaches. In the first, the clonal dissemination of E. coli was evaluated by PFGE using 21 isolates from humans, animals, and environments (sewage). The strains showed high resistance to β-lactams (penicillins and 2nd to 4th generation cephalosporins, monobactams), followed by quinolones, while resistance to aminoglycosides, carbapenems, and tetracyclines/glycylcyclines was low or absent. PFGE analysis identified multiple pulsotypes (A–H) among the isolates, with pulsotype B observed in humans and swine carcasses, pulsotype H in humans and in a canine sample, and pulsotype D in humans, animals, and sewage. In the second approach, 17 genomes were sequenced and analyzed for resistome, viruloma, sequence types (STs), and phylogeny. Thirty-six antimicrobial resistance genes were identified, with mutations associated with quinolone resistance standing out in 53% of the samples. Sixty-four virulence genes were identified, with the most prevalent being csgA, fdeC, fimH, gad, hlyE, nlpl, terC, yehA, yehB, yehC, yehD, and yghJ. Virulence determinants associated with adhesion, iron acquisition, and immune evasion, including lpfA, sitA, iss, traT, and ompT, were detected in human, animal, food, and environmental sources. Among the sequence types (STs) analyzed, ST131 and ST224 stood out, with the former found in four human isolates and the latter present in humans, animals, and the environment, sharing adhesion genes. ST10, identified in an environmental sample, showed low pathogenicity and an absence of resistance genes. Gene co-occurrence analysis revealed that virulence factors predominated in the genetic associations, but that resistance and virulence genes also coexist in several isolates, evidencing the circulation of potentially pathogenic and multidrug-resistant clones at the human-animal-environment interface. The findings reinforce the importance of integrated surveillance and the One Health approach in controlling the spread of multidrug-resistant and potentially pathogenic E. coli. In general, we characterized the genomic profile of E. coli strains from multiple sources and demonstrated their ability to harbor various determinants of resistance and virulence. These results emphasize that antimicrobial resistance is a dynamic, complex, and interconnected phenomenon across different environments. The circulation of the same clones among humans, animals, food, and the environment highlights the interconnectedness within the One Health context. Therefore, this study is important for formulating new surveillance strategies to prevent the spread of high-risk strains across different ecological niches.</description>
      <pubDate>Thu, 23 Apr 2026 00:00:00 GMT</pubDate>
      <guid isPermaLink="false">https://repositorio.ufu.br/handle/123456789/49312</guid>
      <dc:date>2026-04-23T00:00:00Z</dc:date>
    </item>
    <item>
      <title>A Quercetina reduz a infecção por Toxoplasma gondii nos modelos placentários in vitro e ex vivo</title>
      <link>https://repositorio.ufu.br/handle/123456789/49293</link>
      <description>Title: A Quercetina reduz a infecção por Toxoplasma gondii nos modelos placentários in vitro e ex vivo
Abstract: Toxoplasmosis is a disease caused by the obligate intracellular protozoan Toxoplasma gondii, which is capable of infecting all nucleated cells of birds and mammals and is therefore considered one of the most successful parasites in terms of infection. One of the routes of toxoplasmosis transmission is congenital transmission, which most often occurs when the mother acquires the infection for the first time during pregnancy. The ability of the parasite to cross the placental barrier and infect the embryo can lead to fetal malformations, spontaneous abortion, and prematurity, among other manifestations. Currently, the traditional treatment recommended by the Brazilian Ministry of Health consists of spiramycin until the 16th week of pregnancy, followed by the combination of pyrimethamine, sulfadiazine, and folinic acid after the 16th week. However, these treatments have limitations, including teratogenic potential and the possibility of parasite resistance development. Quercetin, for instance, is a natural compound belonging to the flavonol class and is found in fruits and vegetables. It has attracted considerable interest due to its diverse pharmacological properties, particularly its antioxidant activity. In this context, we investigated the use of quercetin as a potential treatment for congenital toxoplasmosis using in vitro, ex vivo, and in silico approaches. We demonstrated that quercetin was able to inhibit intracellular parasite proliferation while preserving cell viability in both in vitro and ex vivo models. In the in vitro model, quercetin impaired parasite adhesion and invasion of host cells, reduced lipid droplet production in T. gondii-infected cells, and preserved antioxidant capacity. In addition, quercetin modulated cytokine production, contributing to the regulation of the immune response and preventing its exacerbation through the modulation of IL-4 and IL-8 expression. Finally, in silico analysis demonstrated affinity for the parasite target TgHGPRT and revealed drug-like characteristics based on the pharmacological properties evaluated. Therefore, quercetin exhibited a potential role in controlling T. gondii parasitism while maintaining a cytoprotective profile, which is essential at the maternal–fetal interface.</description>
      <pubDate>Fri, 24 Jul 2026 00:00:00 GMT</pubDate>
      <guid isPermaLink="false">https://repositorio.ufu.br/handle/123456789/49293</guid>
      <dc:date>2026-07-24T00:00:00Z</dc:date>
    </item>
    <item>
      <title>Perfil de quimiocinas e citocinas séricas e padrões fenotípicos de linfócitos T e B de memória ao longo do envelhecimento humano</title>
      <link>https://repositorio.ufu.br/handle/123456789/48852</link>
      <description>Title: Perfil de quimiocinas e citocinas séricas e padrões fenotípicos de linfócitos T e B de memória ao longo do envelhecimento humano
Abstract: Population aging represents one of the most significant contemporary demographic transformations, driven by increased life expectancy and declining fertility rates, with direct implications for the organization and functionality of the immune system. In this context, this PhD thesis is derived from the integration of three complementary studies investigating immune remodeling across the life course from an immunobiographical perspective. The first study, conducted in older adults, demonstrated a rhythmic increase in circulating inflammatory mediators during aging, particularly CXCL9, CXCL10, IL-1β, IL-6, and TNF, accompanied by a reduction in global connectivity among mediators and a reorganization of inflammatory networks, with increased functional centrality of these molecules. The second study, focused on childhood and adolescence, identified a bimodal pattern in memory cell dynamics, with an initial predominance of naïve cells around 2 years of age, followed by a more pronounced expansion of memory phenotypes between 8–10 years, alongside a progressive increase in connectivity among cellular subsets, especially during adolescence. The third study, encompassing healthy individuals aged 9 months to 65 years, demonstrated that T- and B-cell memory remodeling occurs in discrete, sex-dependent waves, with the most pronounced changes observed at 5–6 years, 10–19 years, and 20–29 years; women exhibited an earlier onset of these changes, whereas men showed greater variability and expansion of differentiated subsets, including effector and interferon-mediated phenotypes. Collectively, these findings indicate that immune remodeling across the lifespan follows dynamic and interconnected patterns involving both cellular compartments and soluble mediators, reflecting cumulative processes shaped by immunobiography. These trajectories, likely modulated by antigenic exposures, environmental factors, and physiological transitions, influence the balance between trained immunity and inflammatory differentiation, ultimately contributing to interindividual variability in immune resilience and susceptibility to chronic inflammatory conditions during aging.</description>
      <pubDate>Fri, 24 Apr 2026 00:00:00 GMT</pubDate>
      <guid isPermaLink="false">https://repositorio.ufu.br/handle/123456789/48852</guid>
      <dc:date>2026-04-24T00:00:00Z</dc:date>
    </item>
    <item>
      <title>Infecção placentária por Trypanosoma cruzi: papel da proteína P21 e avaliação do potencial terapêutico da óleo-resina e extrato hidroalcoólico das folhas de Copaifera multijuga</title>
      <link>https://repositorio.ufu.br/handle/123456789/48810</link>
      <description>Title: Infecção placentária por Trypanosoma cruzi: papel da proteína P21 e avaliação do potencial terapêutico da óleo-resina e extrato hidroalcoólico das folhas de Copaifera multijuga
Abstract: Congenital Chagas disease (CCD), caused by the transplacental transmission of Trypanosoma cruzi, can lead to severe fetal complications. However, the mechanisms of placental barrier transposition and the parasite molecules involved remain poorly understood. Among these molecules, the P21 protein stands out for mediating cellular invasion and proliferation, in addition to exhibiting diverse biological activities. Given the limitations of conventional treatment with benznidazole and nifurtimox, compounds from the Copaifera genus emerge as promising therapeutic alternatives. This study aimed to fulfill two general objectives: (I) to evaluate the effects of the oleoresin (OR) and the leaf hydroalcoholic extract (LHE) of Copaifera multijuga on T. cruzi infection in trophoblastic cells (BeWo) and third-trimester human placental explants; and (II) to investigate the role of P21 in this infection using BeWo cells and both first- and third-trimester placental explants. Regarding the first objective, both compounds reduced invasion, proliferation, and trypomastigote release in BeWo cells and placental explants, altering parasite morphology and modulating the immune response (cytokines and reactive oxygen species). This demonstrates the potential of C. multijuga in controlling infection at the maternal-fetal interface. Regarding the second objective, the absence of P21 (p21-/-) reduced the parasite's invasive capacity in BeWo cells, although it increased its initial proliferation. In placental explants, however, the lack of P21 impaired T. cruzi proliferation, retaining it within the syncytiotrophoblast and altering the local inflammatory profile (particularly in the first trimester), without preventing the infection-induced collagen reduction in the third trimester. In conclusion, the P21 protein is essential for the establishment and modulation of T. cruzi infection at the maternal-fetal interface.</description>
      <pubDate>Fri, 20 Mar 2026 00:00:00 GMT</pubDate>
      <guid isPermaLink="false">https://repositorio.ufu.br/handle/123456789/48810</guid>
      <dc:date>2026-03-20T00:00:00Z</dc:date>
    </item>
  </channel>
</rss>

